A New Era in the Treatment of Chronic Kidney Disease
ProKidney is an advanced biotech company built by innovators who are developing pioneering therapies that aim to transform the medical landscape and change patients’ lives.
ProKidney is a pioneer in the treatment of Chronic Kidney Disease (CKD). While current treatments for CKD can slow the progression of kidney failure, there is no cure for CKD. At ProKidney we are at the forefront in the field of cellular therapy focused on delaying the progression to kidney failure and the need for dialysis.
- ProKidney Reports Third Quarter 2022 Financial Results and Recent Corporate HighlightsNov 14, 2022
- ProKidney to Participate in Upcoming Investor ConferencesNov 11, 2022
- ProKidney Receives Allowance from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for proact 1 (REGEN-006) and EMA Scientific Advice on Phase 3 Protocols of REACT for Diabetic Chronic Kidney DiseaseNov 03, 2022